Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in Sepsis

Sepsis is a state of infection with serious systemic manifestations, and if severe enough, can be associated with multiple organ dysfunction and systemic hypotension, which can cause tissues to be hypoxic. Inflammation, as part of the multifaceted biological response to injurious stimuli, such as pathogens or damaged tissues and cells, underlies these biological processes. Prolonged and persistent inflammation, also known as chronic inflammation, results in progressive alteration in the various types of cells at the site of inflammation and is characterized by the simultaneous destruction and healing of tissue during the process. Tissue hypoxia during inflammation is not just a simple bystander process, but can considerably affect the development or attenuation of inflammation by causing the regulation of hypoxia-dependent gene expression. Indeed, the study of transcriptionally regulated tissue adaptation to hypoxia requires intense investigation to help control hypoxia-induced inflammation and organ failure. In this review, I have described the pathophysiology of sepsis with respect to oxygen metabolism and expression of hypoxia-inducible factor 1.

[1]  L. Figueiredo.  Faculty Opinions recommendation of HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. , 2017 .

[2]  A. Sheel,et al.  Acute mountain sickness, chemosensitivity, and cardiorespiratory responses in humans exposed to hypobaric and normobaric hypoxia. , 2014, Journal of applied physiology.

[3]  S. Herold,et al.  Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[4]  Timothy R Billiar,et al.  In Silico Modeling: Methods and Applications to Trauma and Sepsis , 2013, Critical care medicine.

[5]  K. Hirota.  Hypoxia and Hypoxia-Inducible Factor in Inflammation , 2012 .

[6]  D. Noonan,et al.  Cancer prevention by targeting angiogenesis , 2012, Nature Reviews Clinical Oncology.

[7]  Richard Beale,et al.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[8]  J. Gabert,et al.  Hypoxia-inducible factor (HIF1α) gene expression in human shock states , 2012, Critical Care.

[9]  G. Semenza,et al.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. , 2012, Physiological reviews.

[10]  Sarah C P Williams.  After Xigris, researchers look to new targets to combat sepsis , 2012, Nature Medicine.

[11]  Teppei Shimamura,et al.  Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A , 2012, Molecular and Cellular Biology.

[12]  W. Liles,et al.  Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review , 2012, Critical Care.

[13]  G. Semenza.  Oxygen sensing, homeostasis, and disease. , 2011, The New England journal of medicine.

[14]  I. Woodman.  T cells: A metabolic sHIFt to turn 17 , 2011, Nature Reviews Immunology.

[15]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[16]  Kai Zacharowski,et al.  Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[17]  P. Fagenholz,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[18]  E. So,et al.  Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. , 2011, British journal of anaesthesia.

[19]  P. Carmeliet,et al.  Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. , 2011, The Journal of clinical investigation.

[20]  H. Eltzschig.  Targeting Hypoxia-induced Inflammation. , 2011, Anesthesiology.

[21]  Arthur S Slutsky,et al.  Sepsis and endothelial permeability. , 2010, The New England journal of medicine.

[22]  T. Suganami,et al.  Adipose tissue macrophages: their role in adipose tissue remodeling , 2010, Journal of leukocyte biology.

[23]  J. Takala,et al.  Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions , 2010, PloS one.

[24]  Dean Y. Li,et al.  Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza , 2010, Science Translational Medicine.

[25]  B. Brüne,et al.  HIF-1 in the inflammatory microenvironment. , 2009, Experimental cell research.

[26]  Min Hee Kim,et al.  Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha. , 2009, American journal of physiology. Cell physiology.

[27]  A. Tyagi,et al.  The Microcirculation in Sepsis , 2009, Indian journal of anaesthesia.

[28]  R. Colvin,et al.  Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation , 2009, Proceedings of the National Academy of Sciences.

[29]  P. Carmeliet,et al.  Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease , 2009, Nature Reviews Drug Discovery.

[30]  M. Grocott,et al.  Arterial blood gases and oxygen content in climbers on Mount Everest. , 2009, The New England journal of medicine.

[31]  Seung Yong Park,et al.  Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. , 2008, American journal of respiratory and critical care medicine.

[32]  C. Taylor.  Interdependent roles for hypoxia inducible factor and nuclear factor‐κB in hypoxic inflammation , 2008, The Journal of physiology.

[33]  W. Jelkmann,et al.  Dexamethasone impairs hypoxia-inducible factor-1 function. , 2008, Biochemical and biophysical research communications.

[34]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[35]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[36]  M. Sonobe,et al.  Expression of endothelial cell-specific adhesion molecules in lungs after cardiac arrest. , 2008, Interactive cardiovascular and thoracic surgery.

[37]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[38]  G. Semenza,et al.  Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner , 2008, PloS one.

[39]  Joshua D. Wythe,et al.  Corrigendum: Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability , 2008, Nature Medicine.

[40]  M. Hensel,et al.  Hypoxia and Hypoxia-Inducible Factor-1α Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function1 , 2008, The Journal of Immunology.

[41]  G. Semenza,et al.  LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. , 2008, Antioxidants & redox signaling.

[42]  P. Lepper.  Faculty Opinions recommendation of Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. , 2007 .

[43]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[44]  V. Nizet,et al.  Hypoxia inducible factor (HIF) function in innate immunity and infection , 2007, Journal of Molecular Medicine.

[45]  G. Semenza,et al.  Life with Oxygen , 2007, Science.

[46]  G. Semenza,et al.  ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. , 2007, Antioxidants & redox signaling.

[47]  G. Semenza,et al.  HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. , 2007, Antioxidants & redox signaling.

[48]  B. Brüne,et al.  Nitric oxide and superoxide: interference with hypoxic signaling. , 2007, Cardiovascular research.

[49]  Andre Vercueil,et al.  High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine , 2007, Critical care.

[50]  Judong Pan,et al.  Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis , 2006, Molecular Cancer.

[51]  Shuang-yin Han,et al.  Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. , 2006, Cancer letters.

[52]  G. Semenza,et al.  Activation of hypoxia-inducible factor 1 during macrophage differentiation. , 2006, American journal of physiology. Cell physiology.

[53]  Kiichi Hirota,et al.  Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. , 2005, Biochemical and biophysical research communications.

[54]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[55]  E. Chilvers,et al.  The role of HIF-1α in myeloid cell inflammation , 2005 .

[56]  E. Cummins,et al.  Hypoxia-responsive transcription factors , 2005, Pflügers Archiv.

[57]  H. Malech,et al.  HIF-1α: a master regulator of innate host defenses? , 2005 .

[58]  Hiroshi Nakamura,et al.  TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells1 , 2005, The Journal of Immunology.

[59]  C. Print,et al.  Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.

[60]  G. Semenza,et al.  The intravenous anesthetic propofol inhibits hypoxia‐inducible factor 1 activity in an oxygen tension‐dependent manner , 2004, FEBS letters.

[61]  Fatima Mechta-Grigoriou,et al.  JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress , 2004, Cell.

[62]  C. Shelley,et al.  Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[64]  G. Semenza,et al.  Nitric Oxide Induces Hypoxia-inducible Factor 1 Activation That Is Dependent on MAPK and Phosphatidylinositol 3-Kinase Signaling* , 2004, Journal of Biological Chemistry.

[65]  Thilo Hagen,et al.  Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α , 2003, Science.

[66]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[67]  C. N. Coleman,et al.  Ibuprofen-mediated Reduction of Hypoxia-inducible Factors HIF-1α and HIF-2α in Prostate Cancer Cells , 2003 .

[68]  G. Semenza,et al.  Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. , 2003, Cancer research.

[69]  R. Strieter.  Mastering innate immunity , 2003, Nature Medicine.

[70]  R. Johnson,et al.  A Novel Role for the Hypoxia Inducible Transcription Factor HIF-1alpha: Critical Regulation of Inflammatory Cell Function , 2003, Cell cycle.

[71]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[72]  M. Fink.  Bench-to-bedside review: Cytopathic hypoxia , 2002, Critical care.

[73]  C. Ince.  The microcirculation unveiled. , 2002, American journal of respiratory and critical care medicine.

[74]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[75]  M. Meisner,et al.  Markers of endothelial damage in organ dysfunction and sepsis , 2002, Critical care medicine.

[76]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[77]  R. Busse,et al.  Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.

[78]  J. Pouysségur,et al.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. , 2000, The Journal of biological chemistry.

[79]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[80]  H. Lehr,et al.  Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? , 2000, The Journal of pathology.

[81]  W. Jelkmann,et al.  Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1 , 1999 .

[82]  T. Evans,et al.  Organ dysfunction , 1999, BMJ.

[83]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[84]  A. Peacock.  ABC of oxygen: oxygen at high altitude. , 1998, BMJ.

[85]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Hayden Wr.  Sepsis and organ failure definitions and guidelines. , 1993 .

[87]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[88]  H. K. Bourns.  Management of Sepsis , 1960, The Medical journal of the South-West.

[89]  T. Kodama,et al.  Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seq. , 2014, Kidney international.

[90]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[91]  G. Semenza,et al.  The role of hypoxia-inducible factors in oxygen sensing by the carotid body. , 2012, Advances in experimental medicine and biology.

[92]  M. Dewhirst,et al.  Regulation of HIF-1alpha stability through S-nitrosylation. , 2007, Molecular cell.

[93]  Sujoy Khan.  Acute oxygen-sensing mechanisms. , 2006, The New England journal of medicine.

[94]  E. Chilvers,et al.  The role of HIF-1alpha in myeloid cell inflammation. , 2005, Trends in immunology.

[95]  H. Malech,et al.  HIF-1alpha: a master regulator of innate host defenses? , 2005, The Journal of clinical investigation.

[96]  R. Jaenisch,et al.  HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.

[97]  C. N. Coleman,et al.  Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  D. Higgs,et al.  Articles on similar topics can be found in the following Blood collections , 2002 .

[99]  K. Hirota.  Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression , 2002, Journal of Anesthesia.

[100]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001, Genes & development.

[101]  W. Jelkmann,et al.  Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. , 1999, Blood.

[102]  W. Hayden.  Sepsis and organ failure definitions and guidelines. , 1993, Critical care medicine.